Bold Debates on the Future of Thrombectomy in Stroke: ESOC 2025
European Stroke Organisation (ESO) shared an insightful post on X:
”Couldn’t attend live? Explore one of the key discussions from Day 2 at ESOC 2025 in Helsinki. Our guests debate large core trial results: Are questions still open? Should thrombectomy be for all?”
Watch the key discussions here.
At ESOC 2025 in Helsinki, one of the key discussions on Day 2 centered on the evolving evidence from large core stroke trials.
Experts Anne Hege Nymoen Aamodt and Götz Thomalla debated whether current results fully address the complexities of patient selection and whether thrombectomy should be expanded to all patients.
The session highlighted ongoing uncertainties and the need for further research to refine treatment strategies in this challenging stroke population.

Do not miss the latest updates on global discussions, stay tuned with Hemostasis Today.
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI
-
Nov 8, 2026, 07:16Gilberto de lima Lopes Junior: The Cardiovascular Consequences of Cancer in Younger Patients
-
Nov 8, 2026, 06:51Haney Mallemat: Key Principles and Pitfalls of LVAD Emergencies
-
Nov 8, 2026, 06:31Maria Omer: Clinical Recognition and Management of Cavernous Sinus Thrombosis
-
Nov 8, 2026, 06:16Natasha Jolakoski: University of New Mexico Hospital Promotes PGY-2 Thrombosis and Hemostasis Management Pharmacy Residency
-
Nov 8, 2026, 05:47Safaa Hilal: POCUS in the Evaluation of Perioperative Troponin Elevation